Search Insights

Upcoming Events

TITLE

MiFID II: Impact on the U.S. Market

Trading Chicago

Location:
Chicago, Ill.

Retirement Benefits

American Bankers Association 2017 Trust and Estate Planning Series

Insights

TITLE
Article

U.S. Supreme Court Rejects Class Plaintiffs’ “Voluntary Dismissal” Tactic

The U.S. Supreme Court has decisively rejected a tactic used by class action plaintiffs to attempt to obtain federal appellate review as of right from orders denying class certification.

Article

Supreme Court Decision in BMS Limits Where Companies Can Be Sued

The U.S. Supreme Court’s decision delivered this week in Bristol-Myers Squibb v. Superior Court of California (BMS) reaffirmed the Court’s commitment to limiting state courts’ jurisdiction over national class actions.

Article

SCOTUS Decision Reaffirms Free Speech in Disparaging Trademarks

The U.S. Supreme Court’s Lee v. Tam decision struck down a provision of the federal trademark law.

Event

Partners Speak at FOX Trustees and Beneficiaries Workshop

Family Office Exchange (FOX)

Location:
Atlanta, Ga.
Blog Post

The Dangers of Partial CPSC Reports: The Kawasaki Penalty

Schiff Hardin Product Liability & Mass Torts Blog

Event

Recent Developments in Class Action Settlements

Insurance-Related Class Actions Strafford Publications Webinar

In The News
Article

7th Circuit Affirms Summary Judgment for Dominant Illinois Hospital and its Exclusive Contracts

Last fall, the dominant hospital in Peoria, Ill. won summary judgment against a claim of anticompetitive, exclusive dealing agreements made by its major competitor.

News Release

Former DOJ, IRS Attorney Stuart D. Gibson Joins Schiff Hardin in Washington, D.C.

Schiff Hardin LLP today announced that Stuart D. Gibson has joined the firm’s Tax Group as counsel in the Washington, D.C. office.

Event

Annual Business Valuation Symposium: A Guide to the Changing Legal Environment

Illinois Institute for Continuing Legal Education

Location:
Chicago, Ill.
Article
Article

Supreme Court Delivers Big Patent-Dance-Limiting Win for Biosimilars

Earlier this week, the U.S. Supreme Court unanimously held, in its first case interpreting the Biologics Price Competition and Innovation Act of 2009, Sandoz Inc. v. Amgen Inc.